PHASE 2 STUDY OF PEMBROLIZUMAB PLUS TTFIELDS PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)

被引：0
|
作者：
Tran, David [1 ]
Ghinaseddin, Ashley [2 ]
Chen, Dongjiang [2 ]
Rahman, Maryam [2 ]
机构：
[1] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA
[2] Univ Florida, Gainesville, FL USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTIM-16
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Phase I/pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    Page, Margaretta
    Rabbitt, Jane
    Federoff, Anne
    Parvataneni, Rupa
    Nicol, Steven
    Musib, Luna
    Liepa, Astra
    Thornton, Donald
    Prados, Michael
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3345S - 3345S
  • [32] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S72 - S72
  • [33] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn J.
    Batchelor, Tracy
    Nabors, Burt
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [34] TROTABRESIB (CC-90010) IN COMBINATION WITH CONCOMITANT TEMOZOLOMIDE PLUS RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: UPDATED RESULTS FROM A PHASE 1B/2 STUDY
    Vieito, Maria
    Sepulveda, Juan Manuel
    Moreno, Victor
    de Vos, Filip
    Geurts, Marjolein
    Lorenzi, Elena
    Macchini, Marina
    van den Bent, Martin
    Del Conte, Gianluca
    Martin-Soberon, Maria Cruz
    Brandal, Petter
    Martinez Garcia, Maria
    Amoroso, Barbara
    Sanchez-Perez, Tania
    Zuraek, Marlene
    Hanna, Bishoy
    Filvaroff, Ellen
    Chang, Henry
    Parro, Marina Arias
    Wei, Xin
    Liu, Yu
    Nikolova, Zariana
    Simonelli, Matteo
    NEURO-ONCOLOGY, 2022, 24 : 75 - 75
  • [35] Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
    Stupp, R
    Dietrich, PY
    Kraljevic, SO
    Pica, A
    Maillard, I
    Maeder, P
    Meuli, R
    Janzer, R
    Pizzolato, G
    Miralbell, R
    Porchet, F
    Regli, L
    de Tribolet, N
    Mirimanoff, RO
    Leyvraz, S
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1375 - 1382
  • [36] A PHASE 1/2 STUDY OF THE WEE1 INHIBITOR DEBIO 0123 IN COMBINATION WITH TEMOZOLOMIDE plus RADIOTHERAPY IN ADULTS WITH RECURRENT OR NEWLY DIAGNOSED GLIOBLASTOMA
    Roth, Patrick
    Papadopoulos, Kyriakos P.
    Vieito, Maria
    Yang, Jonathan
    Majd, Nazanin
    Sepulveda, Juan
    Schaff, Lauren
    Moreno, Victor
    Gallego Perez-Larraya, Jaime
    Micallef, Sandrine
    Bellon, Anne
    Omar, Mokhtar
    Imedio, Esteban Rodrigo
    Piggott, Luke
    Rodriguez-Freixinos, Victor
    Rodon, Jordi
    NEURO-ONCOLOGY, 2023, 25
  • [37] Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
    Vieito, Maria
    Simonelli, Matteo
    de Vos, Filip
    Moreno, Victor
    Geurts, Marjolein
    Lorenzi, Elena
    Macchini, Marina
    van den Bent, Martin J.
    Del Conte, Gianluca
    de Jonge, Maja
    Martin-Soberon, Maria Cruz
    Amoroso, Barbara
    Sanchez-Perez, Tania
    Zuraek, Marlene
    Hanna, Bishoy
    Aronchik, Ida
    Filvaroff, Ellen
    Chang, Henry
    Mendez, Cristina
    Arias Parro, Marina
    Wei, Xin
    Nikolova, Zariana
    Sepulveda, Juan Manuel
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [38] PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS
    Reardon, David
    Molinaro, Annette
    Peters, Katherine
    Clarke, Jennifer
    Jordan, Justin
    de Groot, John
    Nghiemphu, Phioanh
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Smith, Timothy
    Cote, David
    Severgnini, Mariano
    Yearley, Jennifer
    Zhao, Qing
    Blumenschein, Wendy
    Duda, Gabriel
    Muzikansky, Alona
    Jain, Rakesh
    Wen, Patrick
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2020, 22 : 40 - 40
  • [39] Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients
    Reardon, David A.
    Nayak, Lakshmi
    Peters, Katherine B.
    Clarke, Jennifer Leigh
    Jordan, Justin T.
    De Groot, John Frederick
    Nghiemphu, Phioanh Leia
    Kaley, Thomas Joseph
    Colman, Howard
    Gaffey, Sarah C.
    Caruso, Victoria
    Debruyne, Myriam Bednarek
    Bhavsar, Chinmay
    Molinaro, Annette M.
    Smith, Timothy
    Severgnini, Mariano
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Patel, Neha
    Khosla, Atulya
    Rauf, Yasmeen
    Stevens, Glen
    Murphy, Erin
    Chao, Samuel
    Yu, Jennifer
    Suh, John
    Peereboom, David
    NEURO-ONCOLOGY, 2022, 24 : 60 - 60
12345